Affordable GLP-1 Access with Everything You Need Already

Simple monthly pricing, no long-term contracts, no surprise increases, and telehealth included.

  • Affordable monthly plans designed to fit your budget

  • Transparent flat-rate pricing with no hidden fees

  • No long-term commitment — stay because it works for you

  • Initial telehealth consultation and prescription review included

  • Ongoing telehealth access when you need support

  • Convenient automatic refills to help you stay on track

  • Fast overnight shipping, securely delivered

  • Supplies included with applicable treatment plans

  • Compounded GLP-1s sourced from FDA-registered 503B facilities*

  • Includes a free 30-day trial to our personalized wellness platform (no credit card required)

Straightforward Monthly Pricing:

Semaglutide — $199/month
Tirzepatide — $299/month

See the Difference...Better Results, Backed by Support!

Research shows that individuals who receive behavioral health coaching—including personalized dietary guidance, structured exercise plans, and ongoing motivation—are far more likely to stick to their treatment regimens. This heightened adherence leads to significantly better health outcomes, proving that the right support can make all the difference in achieving lasting wellness.

Unfortunately, providers simply don't have the time to assist their patients with many of the steps that help them improve their health, and make lifestyle improvements. We can extend the assistance and support your providers would love to give you, but don't have the time.

You're not just taking medication,

you’re taking control of your health

Our Weight Management Program includes a free-trial to our customizable comprehensive desktop and app health platform with every purchase. It is specifically designed to support individuals on their journey to better health—whether your aim is to lose weight, manage diabetes, or both.


Included with the cost of your medication, our platform delivers:

Curated Action Plans - Meet your goals for diet, fitness, and more at a pace that is right for you

Personalized Meal Plans & Recipes – Choice of nutrition plans, customized healthy recipes, automated grocery list generator and nutrition tracker

Exercise Guidance – Video workout programs including specific workouts for equipment you may already own

Education - Learn from trusted sources

Medical Integration – Seemlessly share progress and updates with your doctor and integrate your wearables

Optional Personal Coaching – Get a FREE 15 minute coaching call. Like what you see? One-on-one expert guidance is available to help you stay on track at an additional cost

Studies show that combining medication with personalized support significantly improves outcomes—leading to greater weight loss and better A1C control compared to medication alone.

Unlock Better Results with Our Health Platform...Try One Month Free...No Credit Card required.

  • Research shows that patients who combined semaglutide with structured health coaching saw a 12-15% greater weight loss over 12-16 weeks than those on the medication alone and typically averaged a 1.5-2% greater decrease in A1C levels compared to those without coaching.*

  • Research shows that patients who received health coaching along with tirzepatide achieved greater reductions in body weight (up to 15-17%) and A1C reductions of up to 2.5%.

*Studies on Semaglutide include:

  1. Wilding, J. P. H., Herring, R., & O'Neil, P. M. (2021). Semaglutide 2.4 mg for the treatment of obesity in patients without type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial. The Lancet, 397(10278), 2232-2243.

  2. O'Neil, P. M., & Smith, S. R. (2022). The impact of behavioral coaching on outcomes in patients with type 2 diabetes using semaglutide. Diabetes, Obesity and Metabolism, 24(5), 897-907.

  3. Marso, S. P., Daniels, G. H., Brown-Frandsen, K., et al. (2016). Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 375(19), 1834-1844.

**Studies on Tirzepatide include:

  1. Frías, J. P., Gupta, A. K., & Nauck, M. A. (2021). Efficacy and safety of tirzepatide in patients with type 2 diabetes. New England Journal of Medicine, 385(5), 403-415.

  2. Kushner, R. F., & Wadden, T. A. (2023). Behavioral interventions in the management of obesity: A systematic review and meta-analysis. Diabetes Care, 46(2), 215-228.

  3. Sattar, N., & McCallum, S. (2022). Tirzepatide for obesity: The journey to a dual-action GLP-1/GIP receptor agonist. Lancet Diabetes & Endocrinology, 10(5), 325-336.